ORPHA:137686
Asherman syndrome
Publications
3,758
96.2th percentile
Trials
53
Interventional, condition-specific
Researchers
975
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare, acquired uterine disease characterized by intrauterine adhesions associated with a history of curettage or intrauterine surgery and gynecological symptoms (secondary amenorrhea, hypomenorrhea, pelvic pain, infertility or pregnancy loss).
How rare: 1-5 / 10 000 — about one to five people per ten thousand (still uncommon, but less ultra-rare).
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0015299
- UMLS:C0156372
Additional Mondo synonyms (3)
Asherman's Syndrome · intrauterine adhesions · intrauterine synechiae
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
3,758 matched papers (2,896 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
53 matched on ClinicalTrials.gov (13 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
3,758
3,758 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
3,758 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
2,896 in the last 10 years · medium confidence · 96.2th percentile (publications denominator)
Phrase hits: 3,758 · MeSH hits: 0
Who's working on it?
975
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01
- 02Zhang Y12 papers · 2026
Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, No. 3 Qingchun East Road, Jianggan District, Hangzhou, 310016, China.; Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, No. Qingchun East Road, Jianggan District, Hangzhou, 310016, China.
Papers in Europe PMC - 03Zhang X8 papers · 2026
Department of Obstetrics and Gynecology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Papers in Europe PMC - 04Li Y7 papers · 2026
The Sun Yat-Sen Memorial Hospital Department of Obstetrics and Gynecology, Sun Yat-Sen University, Guangdong, 510080, China.
Papers in Europe PMC - 05Liu D7 papers · 2026
Department of Reproductive Endocrinology, West China Second University Hospital, Sichuan University (Liu, Liu, and Ouyang), Chengdu, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education (Qiao, Liu, Liu, Pei, and Ouyang), Chengdu, China.
Papers in Europe PMC - 06Wang J7 papers · 2026
Department of Obstetrics and Gynecology, University-Town Hospital of Chongqing Medical University, Chongqing 401331, China. Electronic address: 800026@hospital.cqmu.edu.cn.
Papers in Europe PMC - 07Wang X7 papers · 2026
School of Tropical Agriculture and Forestry, Hainan University, Haikou 570228, China.
Papers in Europe PMC - 08Xu D7 papers · 2026
Department of Gynecology, Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Changsha, Hunan, 410013, China. dabaoxu2022@163.com.
Papers in Europe PMC - 09Yang X7 papers · 2026
Department of Obstetrics, The Fifth People's Hospital of Chengdu, Chengdu, China.
Papers in Europe PMC - 10Zhang W7 papers · 2026
Reproductive Medicine Center, Department of Gynecology and Obstetrics, Tangdu Hospital, Air Force Medical University, (Drs. Zhang, Tang, Xiao, Liu, Li and Wang) Xi'an, Shaanxi, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
53
interventional trials for this specific condition
53 interventional trials matched this specific condition name; 13 currently recruiting in our sample.
Data as of 27 July 2026
53 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 97.1th percentile).
medium confidence · 97.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
53 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07280286·NOT YET RECRUITING·Incidence of Intrauterine Adhesions After Myomectomy With Intrauterine Anti-Adhesion Gel
Conditions: Myoma;Uterus · Adhesion; Uterus, Internal·Matched via name phrase
- NCT07421908·RECRUITING·Investigating the Association Between Diagnostic and Therapeutic Management Models and Prognosis of Intrauterine Adhesions Based on a Large-Scale Prospective Cohort Study
Conditions: Intrauterine Adhesion·Matched via name phrase
- NCT05257213·RECRUITING·Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy
Conditions: Intrauterine Adhesion·Matched via name phrase
- NCT07101484·ENROLLING BY INVITATION·A Study of GD007 (Human iPSC-Exosome Liquid Dressing) for Safety and Dose-Finding in Moderate-Severe Intrauterine Adhesions
Conditions: Moderate-Severe Intrauterine Adhesions·Matched via name phrase
- NCT07536971·NOT YET RECRUITING·Clinical Study of i-PRF Intrauterine Perfusion for Endometrial Regeneration and Repair in Moderate to Severe Intrauterine Adhesions
Conditions: Intrauterine Adhesions·Matched via name phrase
- NCT07230600·RECRUITING·AD-SVF Therapy for Refractory Endometrial Infertility
Conditions: Endometrium; Atrophy · Intrauterine Synechiae·Matched via name phrase
- NCT05343572·RECRUITING·Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium
Conditions: Asherman Syndrome · Atrophic Endometrium · Recurrent Implantation Failure·Matched via name phrase
- NCT06608407·ENROLLING BY INVITATION·Platelet Rich Plasma in the Prevention of Adhesion Reformation
Conditions: Intrauterine Adhesion · Asherman Syndrome·Matched via name phrase
- NCT06620978·NOT YET RECRUITING·Impact of Different Saline Pressures During Hysteroscopy on Visibility, Feasibility and Patients' Discomfort
Conditions: Endometrial Polyps · Retained Products of Conception · Lysis of Intrauterine Adhesions · Removal of Retained Intrauterine Device·Matched via name phrase
- NCT07176143·NOT YET RECRUITING·hBMSC Uterine Artery Infusion for Severe IUA-Related Infertility
Conditions: Intrauterine Adhesions·Matched via name phrase
- NCT07697924·RECRUITING·CURENDO (Cord-blood Uterine Regeneration Endometrium): Platelet-rich Plasma Therapy Derived From Umbilical Cord Blood for the Treatment of Endometrial Pathologies (Asherman Syndrome / Endometrial Atrophy / Thin Endometrium)
Conditions: Asherman Syndrome·Matched via name phrase
- NCT06896747·RECRUITING·Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study
Conditions: Thin Endometrial Lining · Female Infertility · Intrauterine Adhesions·Matched via name phrase
- NCT07611474·RECRUITING·To Evaluate the Safety and Effectiveness of Intrauterine Adhesion Preventer in the Prevention and Treatment of Intrauterine Adhesions, a Prospective, Multicenter, Randomized Controlled Clinical Trial
Conditions: Intrauterine Adhesion · Intrauterine Adhesions·Matched via name phrase
Observational and natural-history studies
9 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07160764·NOT YET RECRUITING·Safety and Performance of the Semical Adhesion Barrier Gel for Prevention of Intra-uterine Adhesion
Conditions: Intrauterine Abnormalities in Infertility · Asherman Syndrome · Intra-uterine Adhesions · Postoperative Adhesion of Uterus·Matched via name phrase
- NCT06450301·RECRUITING·Senescent Endometrial Cells in Patients with Thin Endometrial Lining
Conditions: Asherman's Syndrome · Thin Endometrial Lining · Cell Senescence·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Asherman syndrome" OR "Asherman's Syndrome" OR "intrauterine adhesions" OR "intrauterine synechiae"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Asherman syndrome" OR "Asherman's Syndrome" OR "intrauterine adhesions" OR "intrauterine synechiae"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 53 interventional · 9 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T07:28:20.081Z
